Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research

ALMEIDA, ALEXANDRE; BATEMAN, ALEX; BRANDT, CHRISTIAN; DRECHSEL, OLIVER; FUCHS, STEPHAN; HEIDER, DOMINIK; HOOPS, STEFAN; VON KLEIST, MAX; LASSO, GORKA; LÖCHEL, HANNAH F; MATSCHINSKE, JULIAN; MISTRY, JAINA; O?TOOLE, ÁINE NIAMH; RANGEL-PINEROS, GUILLERMO; REINERT, KNUT; ROBERTSON, DAVID L; THEYS, KRISTOF; WILLIAMS, LOWRI; HUFSKY, FRANZISKA; AOUACHERIA, ABDEL; BAUMBACH, JAN; CACCIABUE, MARCO; FINN, ROBERT D; HATTAB, GEORGES; HOFFMANN, MARIE; KADERALI, LARS; KMIECINSKI, RENÓ; LIBIN, PIETER; MARTIN, MARIA J; MCHARDY, ALICE C; NAVRATIL, VINCENT; ONTIVEROS-PALACIOS, NANCY; REDASCHI, NICOLE; REYES, ALEJANDRO; SADEGH, SEPIDEH; UPTON, CHRIS; MARZ, MANJA; LAMKIEWICZ, KEVIN; ARIGHI, CECILIA; BEERENWINKEL, NIKO; CHUGURANSKY, SARA; FRITZ, ADRIAN; HAUSCHILD, ANNE-CHRISTIN; HÖLZER, MARTIN; KALVARI, IOANNA; KÜHNERT, DENISE; LIST, MARKUS; MARTIN, ROMAN; MENDES, PEDRO; NAWROCKI, ERIC P; PETROV, ANTON I; REIMERING, SUSANNE; RICHARDSON, LORNA; SINGER, JOSHUA B; WELZEL, MARIUS

BRIEFINGS IN BIOINFORMATICS

OXFORD UNIV PRESS

Año: 2020

1467-5463

SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a novel virus of the family Coronaviridae. The virus causesthe infectious disease COVID-19. The biology of coronaviruses has been studied for many years. However, bioinformaticstools designed explicitly for SARS-CoV-2 have only recently been developed as a rapid reaction to the need for fast detection,understanding and treatment of COVID-19. To control the ongoing COVID-19 pandemic, it is of utmost importance to getinsight into the evolution and pathogenesis of the virus. In this review, we cover bioinformatics workflows and tools for theroutine detection of SARS-CoV-2 infection, the reliable analysis of sequencing data, the tracking of the COVID-19 pandemicand evaluation of containment measures, the study of coronavirus evolution, the discovery of potential drug targets anddevelopment of therapeutic strategies. For each tool, we briefly describe its use case and how it advances researchspecifically for SARS-CoV-2. All tools are free to use and available online, either through web applications or public coderepositories